Spectralis hra oct

Manufactured by Roland Consult

Sourced in Germany

The Spectralis HRA+OCT is a high-resolution imaging system that combines confocal scanning laser ophthalmoscopy (cSLO) and optical coherence tomography (OCT) technologies. It is designed to provide detailed visualization and analysis of the human eye's structures.

Automatically generated - may contain errors

Lab products found in correlation

3d oct 2000 spectral domain, by Topcon (2 mentions) Retiport erg system, by Roland Consult (2 mentions) Qiaamp dna blood midi kit, by Qiagen (1 mentions)

2 protocols using spectralis hra oct

Comprehensive Ophthalmic Evaluation of CRD

Check if the same lab product or an alternative is used in the 5 most similar protocols

The proband was diagnosed with CRD and recruited at the Department of Ophthalmology, Peking Union Medical College Hospital (PUMCH). Ophthalmic examinations were performed including best-corrected visual acuity (BCVA) testing, fundus examination, optical coherence tomography (OCT, 3D OCT-2000 Spectral Domain; Topcon, Tokyo, Japan), autofluorescence (AF, Spectralis HRA+OCT; Heidelberg, Germany) and electroretinogram (ERG, RetiPort ERG system; Roland Consult, Wiesbaden, Germany). Informed consent was obtained from the patient for this study. Blood samples were obtained from the patient and her parents. This study adhered to the Declaration of Helsinki and was approved by the Institutional Review Board PUMCH.

Dharmat R., Liu W., Ge Z., Sun Z., Yang L., Li Y., Wang K., Thomas K., Sui R, & Chen R. (2017). IFT81 as a Candidate Gene for Nonsyndromic Retinal Degeneration. Investigative Ophthalmology & Visual Science, 58(5), 2483-2490.

+ Open protocol

+ Expand

Molecular Diagnosis of Leber Congenital Amaurosis and Retinitis Pigmentosa

Check if the same lab product or an alternative is used in the 5 most similar protocols

This study was approved by the Institutional Review Board of Peking Union Medical College Hospital (PUMCH) and adhered to the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study. All the probands were diagnosed at the Department of Ophthalmology, PUMCH (Beijing, China) by ophthalmic examinations including best corrected visual acuity (BCVA) testing, fundus examination, optical coherence topography (OCT, 3D OCT-2000 Spectral Domain; Topcon, Tokyo, Japan), visual field tests (Octopus, Interzeag, Schlieren, Switzerland), autofluorescence (AF, Spectralis HRA+OCT; Heidelberg, Germany) and electroretinogram (ERG, RetiPort ERG system, Roland Consult, Wiesbaden, Germany). LCA and RP were diagnosed according to medical and family history, typical fundus and OCT features, visual field defects and attenuated or abolished ERG responses. Blood samples were obtained from all patients and their family members if available. DNA was extracted using QIAamp DNA Blood Midi Kit as instructed by the manufacturer (QIAGEN, Hilden, Germany).

Xu M., Yang L., Wang F., Li H., Wang X., Wang W., Ge Z., Wang K., Zhao L., Li H., Li Y., Sui R, & Chen R. (2015). Mutations in human IFT140 cause non-syndromic retinal degeneration. Human genetics, 134(10), 1069-1078.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!